<DOC>
	<DOCNO>NCT01540578</DOCNO>
	<brief_summary>This clinical trial study biomarkers diagnostic tool sample young patient B-cell acute lymphoblastic leukemia . Finding specific biomarkers may help improve treatment patient B-cell acute lymphoblastic leukemia</brief_summary>
	<brief_title>Studying Biomarkers Diagnostic Tool Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>STUDY SUBTYPE : Ancillary/Correlative OBSERVATIONAL STUDY MODEL : Case-only TIME PERSPECTIVE : Retrospective BIOSPECIMEN RETENTION : Samples DNA BIOSPECIMEN DESCRIPTION : Fresh frozen bone marrow cell STUDY POPULATION DESCRIPTION : Patients B-cell acute lymphoblastic sample bank COG Cell Bank SAMPLING METHOD : Non-probability sample OBJECTIVES : I . To determine whether identify individual within specific sub-group pre-B acute lymphoblastic leukemia ( ALL ) patient eventually recur . II . To identify replication-timing change biomarker risk prediction . III . To identify difference patient similar subtype , choose candidate difference analyze method compatible frozen sample . OUTLINE : Archived cell sample analyze replication time flow cytometry , microarray , single-cell fluorescence situ hybridization ( FISH ) assay . Replication-timing result among case control also analyze .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<criteria>Frozen viable cell sample patient Bcell acute lymphoblastic ( ALL ) outcome Children 's Oncology Group ( COG ) ALL Cell Bank ( Part 1 ) Freshand frozen cell sample patient Bcell ALL know outcome COG ALL Cell Bank ( Part 2 ) meeting 1 follow criterion : Samples patient experience early recurrence within 36 month diagnosis ( case ) Samples patient remain prolonged remission ( control ) No sample meet either follow criterion : Veryhighrisk feature Philadelphia chromosome positive Hypodiploid MLL ( 11q23 ) rearrange Known favorable risk factor Hyperdiploid ( 12 ; 21 ) ( ETV6/RUNX1 )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>